Back to
JPMORGAN CHASE & CO
TLX4 quarters
Position history for
JPMORGAN CHASE & CO's holdings in TELIX PHARMACEUTICAL LTD
Yes. JPMorgan Chase holds 77,538 shares of TLX (Telix Pharmaceutical), worth $876,185, as of its Q2 2026 13F filing. It increased the position by 20,190 shares (+35.2%) from Q1 2026. JPMorgan Chase has held TLX since Q3 2025, across 4 quarterly 13F filings.
Current Value
$876,185
Current Shares
77,538
Total Value Change
+$633,538
Total Shares Change
+52,183
Quarter-by-Quarter History
Other major holders of TLX: FMR LLC, LAZARD ASSET MANAGEMENT LLC, Private Advisor Group, LLC